Scholarlink

<p><i>A. baumannii</i> is a critical nosocomial pathogen with increasing antibiotic resistance. Colistin heteroresistance (CHR), which cannot be detected by standard methods, threatens the effectiveness of this definitive treatment. This study aimed to characterize carbapenem resistance, detect CHR, and investigate its molecular mechanisms. One hundred forty seven <i>A. baumannii</i> isolates were characterized. Carbapenemase genes were detected by PCR, and antibiotic susceptibility was determined by disc diffusion and broth microdilution. Heteroresistance (HR) was detected using population analysis profiling (PAP). The expression of efflux pump (<i>adeB</i>, <i>adeG</i>) and porin (<i>ompA</i>, <i>carO</i>) genes in HR isolates quantified by Real-time PCR analysis. The predominant carbapenemase genes were <i>bla</i><sub>OXA</sub>-51 (97%), <i>bla</i><sub>OXA</sub>-23 (88%), and <i>bla</i><sub>OXA</sub>-24-40 (72%). PAP revealed a prevalence of 8.5% (3/35) of CHR among carbapenem-resistant and colistin-susceptible isolates. Real-time PCR revealed a highly significant (<i>p</i> &lt; 0.001) increase in expression of <i>adeB</i> and <i>adeG</i> (approximately 4-fold) and a concomitant decrease in expression of <i>ompA</i> and <i>carO</i> in these isolates, suggesting a synergistic adaptation mechanism. This study highlights the need for proactive monitoring of CHR for clinical surveillance and management to prevent the emergence of full-scale resistance. Therapeutically, the development of efflux pump inhibitors and molecular diagnostics could be crucial to maintain colistin efficacy and improve treatment outcomes.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Molecular Characterizations of Carbapenem Resistance and Colistin Heteroresistance in Multidrug-Resistant Acinetobacter baumannii

  • 期刊论文

  • 发表日期：

    2026年5月5日

查看全文
  • Nazanin Omidi,
  • Ebrahim Kouhsari,
  • Behrooz Sadeghi Kalani,
  • Vahab Hassan Kaviar,
  • Saeed Khoshnood,
  • Hassan Valadbeigi,
  • Mohammad Hossein Haddadi,
  • Farzaneh Khodaei,
  • Abbas Maleki

摘要

A. baumannii is a critical nosocomial pathogen with increasing antibiotic resistance. Colistin heteroresistance (CHR), which cannot be detected by standard methods, threatens the effectiveness of this definitive treatment. This study aimed to characterize carbapenem resistance, detect CHR, and investigate its molecular mechanisms. One hundred forty seven A. baumannii isolates were characterized. Carbapenemase genes were detected by PCR, and antibiotic susceptibility was determined by disc diffusion and broth microdilution. Heteroresistance (HR) was detected using population analysis profiling (PAP). The expression of efflux pump (adeB, adeG) and porin (ompA, carO) genes in HR isolates quantified by Real-time PCR analysis. The predominant carbapenemase genes were blaOXA-51 (97%), blaOXA-23 (88%), and blaOXA-24-40 (72%). PAP revealed a prevalence of 8.5% (3/35) of CHR among carbapenem-resistant and colistin-susceptible isolates. Real-time PCR revealed a highly significant (p < 0.001) increase in expression of adeB and adeG (approximately 4-fold) and a concomitant decrease in expression of ompA and carO in these isolates, suggesting a synergistic adaptation mechanism. This study highlights the need for proactive monitoring of CHR for clinical surveillance and management to prevent the emergence of full-scale resistance. Therapeutically, the development of efflux pump inhibitors and molecular diagnostics could be crucial to maintain colistin efficacy and improve treatment outcomes.